ArticlePediatric cardiology2026
Pulmonary Comorbidities in Children and Young Adults with Fontan Circulation: The Limitations of General Cardiology Clinics Compared with Dedicated Fontan Clinics.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pathogenesis of pulmonary comorbidities post-Fontan surgery is multifactorial, including long-term, non-pulsatile blood flow, history of multiple sternotomies, abnormal airway lymphatics, associated scoliosis, and recurrent laryngeal nerve or vagal nerve injury as complications of cardiac surgery. A retrospective, cross-sectional analysis of 128 patients under the age of 30 years with a single ventricle status post-Fontan procedure. These patients were evaluated in our multidisciplinary Fontan clinic. Variables relating to demographics, pulmonary diseases, pulmonary function testing measurements, and imaging are described. Outcomes relating to elevated central venous pressure (CVP), pulmonary vascular resistance and transpulmonary gradient (TPG) are also portrayed. Restrictive lung disease was found in 41% of our cohort. Most patients with asthma were previously diagnosed; however, 39% of them required a controller medication change in the clinic. Most of the patients with a confirmed diagnosis of obstructive sleep apnea were screened for sleep disordered breathing and had a polysomnography done for the first time in the Fontan clinic. Reduced forced vital capacity (FVC) z-score < -1.645 was found in 67% of patients with elevated TPG > 6 mmHg (r = -0.143; p = .216.), 50% in patients with elevated pulmonary vascular resistance > 2 Wood units (r = -.137; p = .238), and 35% with elevated mean Fontan pressure > 15 mmHg (r = -.085; p = .464). Our Findings strongly emphasize the pivotal role of dedicated multidisciplinary Fontan clinics with pulmonary involvement in post Fontan care compared to general cardiology clinics given the high prevalence of pulmonary comorbidities post Fontan surgery.
Indexed as
Identifiers
42496701What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.